Introduction: Oral mucositis is an inflammatory toxic reaction that can affect up to 100% of patients undergoing radiotherapy for head and neck cancer.
Objective: This study aimed to promote best practices for the assessment, prevention, and management of oral mucositis in patients undergoing radiotherapy for head and neck cancer.
Method: The study adhered to the seven-phase JBI Evidence Implementation Framework, which is grounded in an audit and feedback process. The study was conducted from October 2022 to August 2023 in the radiotherapy department of a university hospital in Brazil. Eight evidence-based criteria were established to assess compliance with recommendations before and after implementation. Data were analyzed using JBI PACES. Barriers, strategies, and resources were identified using the JBI GRiP approach and improvement strategies were implemented. A follow-up audit was conducted to measure changes in compliance.
Results: In the follow-up audit, six of the eight criteria achieved 100% compliance. These included standardized initial and follow-up oral cavity assessments, treatment of oral mucositis based on damage, education about oral mucositis, oral hygiene protocols, and standardized assessment for malnutrition. The criterion related to the involvement of a multidisciplinary team in treating oral mucositis reached 90% compliance, while the criterion for referring malnourished patients to a nutritionist showed 66.7% compliance.
Conclusions: The high level of compliance with the best practice criteria demonstrates the feasibility of using evidence in clinical practice. The project highlights that strategies and resources can be used to overcome barriers, such as the active involvement of a multidisciplinary team, education, and systematizing the evaluation, prevention, and management of oral mucositis.
Spanish abstract: http://links.lww.com/IJEBH/A442.
扫码关注我们
求助内容:
应助结果提醒方式:
